![]() Seaport Therapeutics Seaport Therapeutics (formerly known as SP Therapeutics) is a clinical-stage therapeutics company. | ![]() Indivior Indivior is a pharmaceutical company focused on developing treatments for substance use disorders and mental health conditions. | ![]() VistaGen Therapeutics VistaGen Therapeutics is a biopharmaceutical company that develops and commercializes intranasal products. | ![]() Newron Pharmaceuticals Newron Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of drugs for the treatment of central nervous system disorders and pain. | ||
Founding Date | Founding Date 2024 | Founding Date 2014 | Founding Date 1998 | Founding Date 2003 | Founding Date 1999 |
Type | Type Public | Type Subsidiary | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Boston, US HQ | Locations Kingston upon Hull, GB HQ | Locations South San Francisco, US HQ | Locations HQ | Locations Milano, IT HQ Bresso, IT Stockholm, SE Zürich, CH Morristown, US |
Employees | Employees 58 | Employees 1,0946% decrease | Employees 9 | Employees 17 | Employees 22 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $1.2b (FY, 2025) | Revenue (est.) $1.3m (FY, 2026) | Revenue (est.) N/A | Revenue (est.) €19.1m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $233m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $1b (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit €19.1m (FY, 2025) |
Net income | Net income N/A | Net income $210m (FY, 2025) | Net income ($69.7m) (FY, 2026) | Net income N/A | Net income (€13.2m) (FY, 2025) |

Indivior is a pharmaceutical company focused on developing treatments for substance use disorders and mental health conditions.
View company
VistaGen Therapeutics is a biopharmaceutical company that develops and commercializes intranasal products.
View company
Newron Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of drugs for the treatment of central nervous system disorders and pain.
View company